Interview Highlights
- Patients with depression who benefit most from TMS are the ones who are less medication resistant with shorter duration of the disorder.
- Relapse rates in patients with depression who underwent TMS are similar to those of ECT; however, TMS does not have the cognitive side effects of ECT.
- TMS for OCD gained FDA’s approval in August 2018.
Text Version
This edition of Psychopharmacology Institute’s Expert Interviews features Simon Kung, M.D.
Dr. Kung is an associate professor of psychiatry at Mayo Clinic in Rochester, Minnesota, and is an expert in transcranial magnetic stimulation (TMS). In this lecture, he will be discussing the background of TMS and how to use it in clinical treatment.
Dana Wang, M.D.: Could you start by telling us
Unlock this Expert Consultation and earn 0.50 CMEs
Become a Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Member.
Already have an account? Sign in
